Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-06

Clinical Trial Update: Evaluation of Dynavisc in Pain Reduction Following Revision Surgery for Persistent or Recurrent Carpal Tunnel Syndrome [NA]

View source ↗

Summary

This is a clinical trial update describing a study evaluating Dynavisc to reduce pain after revision surgery for persistent or recurrent carpal tunnel syndrome;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dynavisc

Snippet

Sponsor: FzioMed | Conditions: Carpal Tunnel Syndrome (CTS) | NA | Status: RECRUITING